Technical Analysis for BTX - BioTime, Inc.

Grade Last Price % Change Price Change
grade F 0.9199 -8.92% -0.09
BTX closed down 8.92 percent on Friday, August 9, 2019, on 1.62 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical BTX trend table...

Date Alert Name Type % Chg
Earnings Movers Other 0.00%
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Gapped Down Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Earnings Movers Other -8.92%
Oversold Stochastic Weakness -8.92%
Stochastic Buy Signal Bullish -8.92%
Lower Bollinger Band Walk Weakness -8.92%

Older signals for BTX ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
BioTime, Inc., a biotechnology company, focuses on regenerative medicine and blood plasma volume expanders. The company primarily focuses on regenerative medicine, which refers to therapies based on human embryonic stem cell and induced pluripotent stem cell technology designed to rebuild cell and tissue function lost due to degenerative disease or injury. It develops and markets research products in the field of stem cells, including an array of proprietary PureStem cell lines and associated ESpan culture media, HyStem hydrogels, and differentiation kits, as well as offers Hextend, a blood plasma volume expander. The company is developing Renevia, a biocompatible, implantable hyaluronan, and collagen-based matrix for cell delivery in human clinical applications; stem cell-based therapies for retinal and neural degenerative diseases; and therapies to treat orthopedic disorders, diseases, and injuries. It is also developing PanC-Dx, a non-invasive blood-based cancer screening test; and therapeutic products for cardiovascular and blood diseases and disorders. In addition, the company markets GeneCards, a human gene database. Further, it is developing an integrated database suite to complement GeneCards that would include the LifeMap database of embryonic development, stem cell research, and regenerative medicine, as well as MalaCards, the human disease database. BioTime, Inc. was founded in 1990 and is headquartered in Alameda, California.
Biotechnology Life Sciences Biology Diseases Stem Cells Emerging Technologies Disorders Therapeutic Products Regenerative Medicine Injury Degenerative Disease Human Disease Induced Stem Cells Injuries Biotime Culture Media Embryonic Stem Cell Renevia
Is BTX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 2.81
52 Week Low 0.66
Average Volume 428,707
200-Day Moving Average 1.2672
50-Day Moving Average 1.0766
20-Day Moving Average 1.103
10-Day Moving Average 1.0509
Average True Range 0.0804
ADX 19.22
+DI 11.8834
-DI 26.1399
Chandelier Exit (Long, 3 ATRs ) 1.0188
Chandelier Exit (Short, 3 ATRs ) 1.1412
Upper Bollinger Band 1.2737
Lower Bollinger Band 0.9323
Percent B (%b) -0.04
BandWidth 30.951949
MACD Line -0.0349
MACD Signal Line -0.0111
MACD Histogram -0.0238
Fundamentals Value
Market Cap 106.53 Million
Num Shares 116 Million
EPS 0.60
Price-to-Earnings (P/E) Ratio 1.53
Price-to-Sales 81.83
Price-to-Book 1.49
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.02
Resistance 3 (R3) 1.03 1.00 1.01
Resistance 2 (R2) 1.00 0.97 1.00 1.00
Resistance 1 (R1) 0.96 0.96 0.98 0.95 1.00
Pivot Point 0.93 0.93 0.94 0.93 0.93
Support 1 (S1) 0.89 0.90 0.91 0.88 0.84
Support 2 (S2) 0.86 0.89 0.86 0.84
Support 3 (S3) 0.82 0.86 0.83
Support 4 (S4) 0.81